Registration

MEDSECUREAN.COM for INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Trade (domestic/foreign) TRD

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Homeland Security HOM

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Defense DEF

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Disaster Planning/Emergencies DIS

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.

LobbyistCovered position, as disclosed
KATHLEEN JAEGER New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
INDIAN PHARMACEUTICAL ALLIANCE India India 100.0% $75,000

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.